Search

Your search keyword '"Mello, Wallace De"' showing total 13 results
Start Over Author "Mello, Wallace De"
13 results on '"Mello, Wallace De"'

1. Additional file 4: Figure S1. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Author

Pinto-Mariz, Fernanda, Carvalho, Luciana Rodrigues, Araujo, Alexandra Prufer De Queiroz Campos, Mello, Wallace De, Mårcia GonçAlves Ribeiro, Cunha, Maria, Cabello, Pedro, Riederer, Ingo, Negroni, Elisa, Desguerre, Isabelle, Veras, Mariana, Yada, Erica, Allenbach, Yves, Benveniste, Olivier, Voit, Thomas, Mouly, Vincent, Silva-Barbosa, Suse, Butler-Browne, Gillian, and Savino, Wilson

Subjects
3. Good health
Abstract

Gating procedures for cytofluorometric labeling of CD49d in freshly isolated leukocytes from the blood of normal subjects and Duchenne muscular dystrophy patients. (DOC 108 kb)

2. Additional file 1: Table S1. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Author

Pinto-Mariz, Fernanda, Carvalho, Luciana Rodrigues, Araujo, Alexandra Prufer De Queiroz Campos, Mello, Wallace De, Mårcia GonçAlves Ribeiro, Cunha, Maria, Cabello, Pedro, Riederer, Ingo, Negroni, Elisa, Desguerre, Isabelle, Veras, Mariana, Yada, Erica, Allenbach, Yves, Benveniste, Olivier, Voit, Thomas, Mouly, Vincent, Silva-Barbosa, Suse, Butler-Browne, Gillian, and Savino, Wilson

Subjects
musculoskeletal diseases, congenital, hereditary, and neonatal diseases and abnormalities, nervous system diseases, 3. Good health
Abstract

General characteristics of the DMD patients enrolled in the study of blood samples. (DOC 35 kb)

3. Additional file 5: Figure S2. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Author

Pinto-Mariz, Fernanda, Carvalho, Luciana Rodrigues, Araujo, Alexandra Prufer De Queiroz Campos, Mello, Wallace De, Mårcia GonçAlves Ribeiro, Cunha, Maria, Cabello, Pedro, Riederer, Ingo, Negroni, Elisa, Desguerre, Isabelle, Veras, Mariana, Yada, Erica, Allenbach, Yves, Benveniste, Olivier, Voit, Thomas, Mouly, Vincent, Silva-Barbosa, Suse, Butler-Browne, Gillian, and Savino, Wilson

Subjects
3. Good health
Abstract

Lack of differences between DMD patients and healthy control in relative numbers of CD14/CD49dhi and CD19/CD49dhi cells. (DOC 69 kb)

4. Additional file 6: Figure S3. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Author

Pinto-Mariz, Fernanda, Carvalho, Luciana Rodrigues, Araujo, Alexandra Prufer De Queiroz Campos, Mello, Wallace De, Mårcia GonçAlves Ribeiro, Cunha, Maria, Cabello, Pedro, Riederer, Ingo, Negroni, Elisa, Desguerre, Isabelle, Veras, Mariana, Yada, Erica, Allenbach, Yves, Benveniste, Olivier, Voit, Thomas, Mouly, Vincent, Silva-Barbosa, Suse, Butler-Browne, Gillian, and Savino, Wilson

Subjects
musculoskeletal diseases, congenital, hereditary, and neonatal diseases and abnormalities, macromolecular substances, 3. Good health
Abstract

Higher numbers of CD49dhi T cells in fast, but not in slow, progressors DMD patients correlate with disease severity. (DOC 59 kb)

5. Additional file 2: Table S2. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Author

Pinto-Mariz, Fernanda, Carvalho, Luciana Rodrigues, Araujo, Alexandra Prufer De Queiroz Campos, Mello, Wallace De, Mårcia GonçAlves Ribeiro, Cunha, Maria, Cabello, Pedro, Riederer, Ingo, Negroni, Elisa, Desguerre, Isabelle, Veras, Mariana, Yada, Erica, Allenbach, Yves, Benveniste, Olivier, Voit, Thomas, Mouly, Vincent, Silva-Barbosa, Suse, Butler-Browne, Gillian, and Savino, Wilson

Subjects
musculoskeletal diseases, congenital, hereditary, and neonatal diseases and abnormalities, 3. Good health
Abstract

Age-related features of DMD patients enrolled in the evaluation of muscle biopsies. (DOC 37 kb)

6. Additional file 3: Table S3. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Author

Pinto-Mariz, Fernanda, Carvalho, Luciana Rodrigues, Araujo, Alexandra Prufer De Queiroz Campos, Mello, Wallace De, Mårcia GonçAlves Ribeiro, Cunha, Maria, Cabello, Pedro, Riederer, Ingo, Negroni, Elisa, Desguerre, Isabelle, Veras, Mariana, Yada, Erica, Allenbach, Yves, Benveniste, Olivier, Voit, Thomas, Mouly, Vincent, Silva-Barbosa, Suse, Butler-Browne, Gillian, and Savino, Wilson

Subjects
3. Good health
Abstract

Antibodies applied in cytofluorometry and immunohistochemistry. (DOC 57 kb)

7. Additional file 2: Table S2. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Author

Pinto-Mariz, Fernanda, Carvalho, Luciana Rodrigues, Araujo, Alexandra Prufer De Queiroz Campos, Mello, Wallace De, Mårcia GonçAlves Ribeiro, Cunha, Maria, Cabello, Pedro, Riederer, Ingo, Negroni, Elisa, Desguerre, Isabelle, Veras, Mariana, Yada, Erica, Allenbach, Yves, Benveniste, Olivier, Voit, Thomas, Mouly, Vincent, Silva-Barbosa, Suse, Butler-Browne, Gillian, and Savino, Wilson

Subjects
musculoskeletal diseases, congenital, hereditary, and neonatal diseases and abnormalities, 3. Good health
Abstract

Age-related features of DMD patients enrolled in the evaluation of muscle biopsies. (DOC 37 kb)

8. Additional file 7: Figure S4. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Author

Pinto-Mariz, Fernanda, Carvalho, Luciana Rodrigues, Araujo, Alexandra Prufer De Queiroz Campos, Mello, Wallace De, Mårcia GonçAlves Ribeiro, Cunha, Maria, Cabello, Pedro, Riederer, Ingo, Negroni, Elisa, Desguerre, Isabelle, Veras, Mariana, Yada, Erica, Allenbach, Yves, Benveniste, Olivier, Voit, Thomas, Mouly, Vincent, Silva-Barbosa, Suse, Butler-Browne, Gillian, and Savino, Wilson

Subjects
musculoskeletal diseases, congenital, hereditary, and neonatal diseases and abnormalities, 3. Good health
Abstract

Ex vivo anti-CD49d antibody treatment blocks lymphocyte-myotube adhesion in DMD patients. (DOC 520 kb)

9. Additional file 6: Figure S3. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Author

Pinto-Mariz, Fernanda, Carvalho, Luciana Rodrigues, Araujo, Alexandra Prufer De Queiroz Campos, Mello, Wallace De, Mårcia GonçAlves Ribeiro, Cunha, Maria, Cabello, Pedro, Riederer, Ingo, Negroni, Elisa, Desguerre, Isabelle, Veras, Mariana, Yada, Erica, Allenbach, Yves, Benveniste, Olivier, Voit, Thomas, Mouly, Vincent, Silva-Barbosa, Suse, Butler-Browne, Gillian, and Savino, Wilson

Subjects
musculoskeletal diseases, congenital, hereditary, and neonatal diseases and abnormalities, macromolecular substances, 3. Good health
Abstract

Higher numbers of CD49dhi T cells in fast, but not in slow, progressors DMD patients correlate with disease severity. (DOC 59 kb)

10. Additional file 3: Table S3. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Author

Pinto-Mariz, Fernanda, Carvalho, Luciana Rodrigues, Araujo, Alexandra Prufer De Queiroz Campos, Mello, Wallace De, Mårcia GonçAlves Ribeiro, Cunha, Maria, Cabello, Pedro, Riederer, Ingo, Negroni, Elisa, Desguerre, Isabelle, Veras, Mariana, Yada, Erica, Allenbach, Yves, Benveniste, Olivier, Voit, Thomas, Mouly, Vincent, Silva-Barbosa, Suse, Butler-Browne, Gillian, and Savino, Wilson

Subjects
3. Good health
Abstract

Antibodies applied in cytofluorometry and immunohistochemistry. (DOC 57 kb)

11. Additional file 5: Figure S2. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Author

Pinto-Mariz, Fernanda, Carvalho, Luciana Rodrigues, Araujo, Alexandra Prufer De Queiroz Campos, Mello, Wallace De, Mårcia GonçAlves Ribeiro, Cunha, Maria, Cabello, Pedro, Riederer, Ingo, Negroni, Elisa, Desguerre, Isabelle, Veras, Mariana, Yada, Erica, Allenbach, Yves, Benveniste, Olivier, Voit, Thomas, Mouly, Vincent, Silva-Barbosa, Suse, Butler-Browne, Gillian, and Savino, Wilson

Subjects
3. Good health
Abstract

Lack of differences between DMD patients and healthy control in relative numbers of CD14/CD49dhi and CD19/CD49dhi cells. (DOC 69 kb)

12. Additional file 4: Figure S1. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Author

Pinto-Mariz, Fernanda, Carvalho, Luciana Rodrigues, Araujo, Alexandra Prufer De Queiroz Campos, Mello, Wallace De, Mårcia GonçAlves Ribeiro, Cunha, Maria, Cabello, Pedro, Riederer, Ingo, Negroni, Elisa, Desguerre, Isabelle, Veras, Mariana, Yada, Erica, Allenbach, Yves, Benveniste, Olivier, Voit, Thomas, Mouly, Vincent, Silva-Barbosa, Suse, Butler-Browne, Gillian, and Savino, Wilson

Subjects
3. Good health
Abstract

Gating procedures for cytofluorometric labeling of CD49d in freshly isolated leukocytes from the blood of normal subjects and Duchenne muscular dystrophy patients. (DOC 108 kb)

13. Additional file 1: Table S1. of CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy

Author

Pinto-Mariz, Fernanda, Carvalho, Luciana Rodrigues, Araujo, Alexandra Prufer De Queiroz Campos, Mello, Wallace De, Mårcia GonçAlves Ribeiro, Cunha, Maria, Cabello, Pedro, Riederer, Ingo, Negroni, Elisa, Desguerre, Isabelle, Veras, Mariana, Yada, Erica, Allenbach, Yves, Benveniste, Olivier, Voit, Thomas, Mouly, Vincent, Silva-Barbosa, Suse, Butler-Browne, Gillian, and Savino, Wilson

Subjects
musculoskeletal diseases, congenital, hereditary, and neonatal diseases and abnormalities, nervous system diseases, 3. Good health
Abstract

General characteristics of the DMD patients enrolled in the study of blood samples. (DOC 35 kb)

Catalog

Books, media, physical & digital resources
See catalog results